You have 9 free searches left this month | for more free features.

DuoBody®

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

Available
  • Large B-cell Lymphoma
  • +4 more
  • Epcoritamab
  • (no location specified)
Feb 16, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

Not yet recruiting
  • Follicular Lymphoma
  • Low Grade Non-Hodgkin's Lymphoma, Adult
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Solid Tumor Trial in Tokyo (GEN1046)

Recruiting
  • Solid Tumor
  • GEN1046
  • Tokyo, Japan
  • +1 more
Jan 13, 2023

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Leukemia, Myeloid, Acute Trial in Spain, United States (JNJ-63709178)

Completed
  • Leukemia, Myeloid, Acute
  • Detroit, Michigan
  • +9 more
Aug 30, 2021

Breast Cancer, Uterine Cancer, Ovarian Cancer Trial in Denmark, France, Spain (GEN1047 is a bispecific antibody that induces

Recruiting
  • Breast Cancer
  • +3 more
  • GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
  • Copenhagen, Denmark
  • +5 more
Jul 25, 2022

Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome Trial in Worldwide (Epcoritamab)

Recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Richter's Syndrome
  • Epcoritamab
  • Tuscaloosa, Alabama
  • +22 more
Jun 15, 2022

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s), Expansion Part: Prostate Cancer, Expansion Part: Esophageal

Terminated
  • Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s)
  • +7 more
  • GEN1044 is an IgG1 bispecific antibody targeting CD3 and 5T4.
  • Nashville, Tennessee
  • +5 more
Mar 1, 2022

DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
  • +7 more
  • Birmingham, Alabama
  • +61 more
Apr 13, 2022

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • GEN1046
  • Pembrolizumab
  • Santa Rosa, California
  • +26 more
Jan 30, 2023

Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • +7 more
  • GEN3009
  • Epcoritamab
  • Tucson, Arizona
  • +31 more
Jul 1, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Epcoritamab
  • Investigator's Choice Chemotherapy
  • Irvine, California
  • +254 more
Jan 9, 2023

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

Recruiting
  • Atrial Fibrillation
  • Heart rhythm measurements with Preventicus®
  • +3 more
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Aug 28, 2023

ECMO Braile Biomédica® in COVID-19 Patients

Recruiting
  • COVID-19
  • Patients underwent cardiorespiratory support
  • Lago Sul, Brasília - DF, Brazil
    Hospital Brasília
Oct 13, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

Recruiting
  • Venous Leg Ulcer
  • Diabetic Foot
  • AQUACEL® Ag+ Extra™
  • Cutimed® Sorbact®
  • Barranquilla, Colombia
  • +13 more
May 26, 2023

Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

Recruiting
  • Dental Implants
  • Dynamic Computer Assisted Surgery
  • Freehand
  • L´hospitalet de Llobregat, Catalunya, Spain
    University of Barcelona
Aug 31, 2023

Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

Completed
  • Carpal Tunnel Syndrome
  • KForce Sens
  • Baseline Electrıgoniometer
  • Denizli, Turkey
    Pamukkale University
Sep 14, 2023

Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

Not yet recruiting
  • Tricuspid Regurgitation
  • Tricuspid Valve Disease
  • TricValve® Transcatheter Bicaval Valve System
  • Medical Therapy Arm
  • Cleveland, Ohio
  • +10 more
Nov 14, 2023